Delivery Order SPE2DB20D2104-SPE2DB25FMHDC

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $45,512.89, is for Ozempic 0.25-0.5 mg/dose pens. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Ozempic 0.25-0.5 mg/dose pens. The $2,860.16 firm fixed-price contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,466.72 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a firm fixed price of $30,072.94 and a period of performance through January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL. The delivery order has a firm fixed price of $4,064.01 and a completion date of May 15, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, with a ceiling value of $5,350.45. The contract has a firm fixed price pricing type and an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,939.24 firm fixed-price contract is for the provision of Ozempic 0.25-0.5 mg/dose pens. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a $2,362.29 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3mL. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military healthcare. This...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $26,675.53 and runs through December 27, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,799.93 firm fixed-price contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens to support military healthcare programs. The contract has an ultimate completion date of December 31, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHDC
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Ozempic 0.25-0.5 mg/dose pens. The $3,575.38 firm-fixed-price contract has a completion date of February 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order does not have a set-aside designation, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply procurement programs.

Generated 5/2/25, 10:09 AM